US Bancorp’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,751
| Closed | -$11K | – | 4103 |
|
|
2023
Q4 | $11K | Buy |
+12,751
| New | +$11K | ﹤0.01% | 3293 |
|
|
2023
Q3 | – | Sell |
-452
| Closed | -$1.17K | – | 4085 |
|
|
2023
Q2 | $1.17K | Sell |
452
-1,209
| -73% | -$3.13K | ﹤0.01% | 3752 |
|
|
2023
Q1 | $6.78K | Buy |
1,661
+472
| +40% | +$1.93K | ﹤0.01% | 3408 |
|
|
2022
Q4 | $5.97K | Buy |
1,189
+1,051
| +762% | +$5.28K | ﹤0.01% | 3444 |
|
|
2022
Q3 | $2K | Buy |
138
+73
| +112% | +$1.06K | ﹤0.01% | 3860 |
|
|
2022
Q2 | $1K | Sell |
65
-421
| -87% | -$6.48K | ﹤0.01% | 4009 |
|
|
2022
Q1 | $7K | Buy |
486
+177
| +57% | +$2.55K | ﹤0.01% | 3504 |
|
|
2021
Q4 | $5K | Buy |
309
+203
| +192% | +$3.29K | ﹤0.01% | 3649 |
|
|
2021
Q3 | $2K | Buy |
+106
| New | +$2K | ﹤0.01% | 3899 |
|
|
2021
Q2 | – | Sell |
-270
| Closed | -$8K | – | 4057 |
|
|
2021
Q1 | $8K | Hold |
270
| – | – | ﹤0.01% | 3368 |
|
|
2020
Q4 | $8K | Buy |
+270
| New | +$8K | ﹤0.01% | 3260 |
|
|
2020
Q3 | – | Sell |
-45
| Closed | -$1K | – | 3797 |
|
|
2020
Q2 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 3585 |
|